🇺🇸
United States · US · US:0088-2220_4e220385-b760-4a64-a1ca-84bd2bebe448
Lantus
In shortageUNIISPLATC A10AE04
Last synced from FDA National Drug Code directory (United States) on
Identification
Manufacturersanofi-aventis U.S. LLC
CountryUS (United States)
ATC codeA10AE04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1100882220331 VIAL, GLASS in 1 CARTON (0088-2220-33) / 10 mL in 1 VIAL, GLASS
- ndc1100882220341 VIAL, GLASS in 1 CARTON (0088-2220-34) / 10 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
2ZM8CX04RZ
INSULIN GLARGINE
RxCUI 274783
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Lispro-aabc Injection
Raw payload (JSON)
{
"unii": {
"unii": "2ZM8CX04RZ",
"rxcui": "274783",
"inchikey": null,
"display_name": "INSULIN GLARGINE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"d5e07a0c-7e14-4756-9152-9fea485d654a": {
"match": "brand_token",
"title": "LANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]",
"spl_version": "35",
"published_date": "2025-07-02"
}
},
"productid": "0088-2220_4e220385-b760-4a64-a1ca-84bd2bebe448",
"productndc": "0088-2220",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN GLARGINE",
"shortage_reason": "Insulin Lispro-aabc Injection",
"shortage_status": "current",
"proprietary_name": "Lantus",
"active_ingred_unit": "[iU]/mL",
"application_number": "BLA021081",
"marketing_category": "BLA",
"nonproprietary_name": "insulin glargine",
"start_marketing_date": "20090923",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code A10AE04.
Access this data programmatically
Query Lantus and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.